VulnerabilityModified
CVE-2022-38786
Improper access control in some Intel Battery Life Diagnostic Tool software before version 2.2.1 may allow an authenticated user to potentially enable escalation of privilege via local access.
HIGH 7.8EPSS 0.17%
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (0.17%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
Improper access control in some Intel Battery Life Diagnostic Tool software before version 2.2.1 may allow an authenticated user to potentially enable escalation of privilege via local access.
- CVSS 3.1
- 7.8 HIGHCVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
- EPSS
- 0.17% probability · 6th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-284
- Affected
- intel/battery life diagnostic tool
- Source
- secure@intel.com
References
- https://www.intel.com/content/www/us/en/security-center/advisory/intel-sa-00843.htmlPatch, Vendor Advisory
- https://www.intel.com/content/www/us/en/security-center/advisory/intel-sa-00843.htmlPatch, Vendor Advisory
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.